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One  of three  splenic  B  cells  has  been  found  to  react  with  the  B-cell  mitogen 
lipopolysaccharide (LPS) 1 (1) by clonal growth and maturation to IgM secretion (2). 
Similar frequencies have been found  for lipoprotein  (LP)  (3,  4)-reactive B cells,  for 
Nocardia mitogen (NOC)  (5)-reactive B cells (our unpublished observations) and for 
B cells which are reactive to mitogenic compounds in fetal calf serum (mFCS)  (6,  7 
and our unpublished observations). 
We investigate in this paper whether different B-cell stimuli, LPS, LP, NOC, and 
mFCS, stimulate the same or different populations of B-cell blasts to growth and IgM 
secretion. We do this by activating small, resting B cells (8) from 2- to 3-mo-old adult 
C57BL/6j- or C3H/a-if spleen with either LPS or LP, by separating the activated, large 
B-cell blasts from the nonactivated, small lymphocytes by velocity sedimentation (9), 
and  by continuing  the  growth  and  maturation  of the activated  B-cell blasts either 
with  the same or with  a  different  mitogen. We induce  and  maintain  B-cell growth 
and  maturation  under  improved  culture  conditions  (10,  i1),  replacing  FCS  by 
albumin,  transferrin,  and  soybean  lipid  in  a  further enriched  Dulbecco's modified 
Eagle's medium. This excludes the mitogens contained in FCS and allows lymphocytes 
to survive better, as compared to FCS-supplemented media. We monitor B-cell growth 
by the increase in the number of cells in  the culture,  and  B-cell maturation  by the 
number of Ig-secreting cells detected with the Protein A hemolytic plaque test which 
detects all secreting cells regardless of the combining site specificity of the secreted Ig 
(12).  The number of reactive B-cells is determined  in cultures  limiting the reactive 
cells to near one (2). 
The results presented in this paper suggest that one B cell activated by one B-cell 
mitogen  needs  the  continued  presence  and  stimulation  of a  mitogen  to  continue 
growth and maturation.  This mitogen, for a  large fraction of all activated splenic B 
cells, can be replaced by other mitogenic stimuli.  It suggests that a  large proportion 
of activated adult splenic B-cell blasts are reactive to more than one mitogen. C3H/Hej 
mice are unreactive to LPS (13).  Because C3H/nea-B-cell blasts, activated by LP, do 
not continue to grow and mature with LPS, but with all the other growth stimuli, it 
appears that  this continuation  of B-cell growth  is not  unspecific. We conclude  that 
one activated B cell expresses a  number of different  reactivities, and thus, probably 
receptors specific for various B-cell mitogens. 
* Supported by a grant from the Swedish Cancer Society. 
' Abbrevations used in this paper." BSS, balanced salt solution; FCS, fetal calf, serum; LP, lipoprotein; LPS, 
lipopolysaccharide; mFCS, mitogenic  compounds in fetal calf serum; NOC, nocardia mitogen. 
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Materials  and  Methods 
Animals.  C3H/Te/BOM mice,  6-8  wk  old,  were  obtained  from  Gr.  Bomholtgaard,  Ry, 
Denmark. C3H/HeJ/Fa1 mice and C57BL/6j mice, 6- to 8-wk old of age and Lewis strain rats, 
4  wk  old,  were  obtained  from  the  Institut  fiir Biologisch-Medizinische Forschung,  A.  G., 
Fiillinsdorf, Switzerland. 
Cell Cultures.  Mouse spleen cells were prepared as described previously (2, 4) and cultured 
in a  modified Dulbecco's modified Eagle's medium (11) containing albumin, transferrin, and 
soybean lipid instead of FCS, 2-mercaptoethanol (5 ×  105 M) and kanamyein (Gibco Bio-Cult, 
Irvine, Scotland). Mass cultures were initiated at 3 ×  105 eells/ml. Cultures at limiting dilutions 
of reactive B cells contained 3  ×  l0  s rat thymus eells/ml as growth-supporting filler cells (2, 
14). Separation of cells of different size was done by velocity sedimentation (9) using a gradient 
of 2-4% bovine serum albumin (Sigma Chemical Co., St. Louis, Mo.) in balanced salt solution 
(BSS). After separation, cell fractions were washed with BSS and then either recultured in mass 
cultures at  1 ×  105 cells/ml or in limiting dilutions in 3  ×  106 rat filler cells/ml. 
Mitogens.  LPS-S (smooth-form lipopolysaccharide from Salmonella abortus equi) was kindly 
prepared for us by Doctors C.  Galanos and  O.  Lfideritz, Max-Planck-Institut, Freiburg im 
Breisgau, West Germany. It was routinely used at 50/~g/ml in culture (4). LP form the outer 
cell wall of Escherichia coli was prepared according to the methods of Braun and coworkers (14, 
15)  from E.  coli 3,300.  It was further purified by electrodialysis  2 and  found to contain <1% 
LPS, in fact, undetectable quantities. It was used at 5 #g/ml in culture. NOC  (5), a gift from 
Dr. C. Bona, Institut Pasteur, Paris, was used at 4 #g/ml. FCS, batch U951801  (Gibco Bio- 
Cult, Glasgow, Scotland) (16) was used at  10% as a source of mitogens of FCS (mFCS). 
Assays.  Cultures were assayed for the number of cells secreting either IgM or IgGl+2 by the 
protein A-SRC plaque assay (12). Protein A was prepared for us by Dr. H. Wigzell, Biomedicum, 
University of Uppsala, Uppsala, Sweden. Antibodies against purified MOPC  104E  19S IgM 
(~.,/t), against MOPC21  IgG, ('tx,~), and against anti-PC-5 IgG2 (y2,K) were raised in rabbits by 
repeated injections of 0.5-1 mg of the myeloma protein in incomplete Freund's adjuvants, and 
titrated for their optimal developing capacity in the plaque assay with Ig-secreting myeloma 
cell lines and LPS-stimulated spleen cells. 
Results 
Activation  of Small,  Resting  Splenic  Lymphocytes by  the Mitogen  LPS and LP.  Splenic 
lymphocytes of 6-12 wk-old C57BL/6j/r~a or C3H/Tif/BOM mice, reactive to LPS and 
LP, and of Call~Hejira1  mice, reactive to LP but unreactive to LPS, were enriched for 
small, resting cells by velocity sedimentation  (9, see also Fig.  1 in Reference 8).  The 
small  cells were  then  cultured  in  the  absence  or  presence  of either  LPS  or  LP  for 
36-48  h  in  the  modified medium  supplied with  albumin,  transferrin,  and  soybean 
lipid  as  serum  substitutes.  After  the  activation  period,  cells were  counted.  Large, 
activated cells were distinguished from small, nonactivated cells (Table I). 
As  expected,  C3H/Hej/ral  spleen  cells  did  not  respond  to  LPS  but  only  to  LP, 
whereas C57BL/6a/ral and CaH/Tif/BOM spleen cells were activated both by LPS and 
by LP.  In  the  absence of mitogens,  cells remained small;  the  total number  of cells 
decreased only slightly or remained unchanged, also in the case of the LPS- nonacti- 
vated  CaH/H~J/Fal  cells.  This  again,  documents  the  observed  (11)  high  survival  of 
murine  lymphocytes in  the  improved tissue culture medium.  Wherever spleen cells 
appeared activated by mitogen approximately one-half of all cells were large, and the 
total  number  of cells increased slightly. These  figures can  be  accounted  for by the 
frequencies of mitogen-reactive cells which can  be expected to divide an  average of 
two times within 36-48 h  of activation (2). 
Separation  of  the  Activated  Large  Cells from  the  Nonactivated  Small  Cells by  Velocity 
Ga|anos, C., O. Liideritz, and F. Melchers. Manuscript  in preparation. JAN ANDERSSON ET AL. 
TABL~  I 
Survival and Activation of Small Lymphocytes in the Initial Activation Period 
Cell source 
Activation by 
LPS  LP  0 
Cells per ml 
a)  C57BL/~a/Fiil* 
Small  2.3  X  l0  s  2.4  ×  l0  s  2.9 ×  l0  s 
Large  1.8 X  l0  s  1.6 X  l0  s  104 
b)  CaH/Tif/BOM:~ 
Small  2.3  X  l0  s  2.2  X  l0  s  ND 
Large  2.0  x  l0  s  1.8  x  l0  s  ND 
c)  C3H/n,a/~§ 
Small  2.9  X  10  s  2.4  X  l0  s  3.1  X  l0  s 
Large  10  ~  1.6 X  l0  s  104 
ND, not done. 
* Activation period 44 h, initial cell concentration 3 ×  10S/ml. 
:~ Activation period 48 h, initial cell concentration 3 ×  10S/ml, 
§ Activation period 45 h, initial cell concentration 3 ×  10S/ml. 
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Fro.  1.  Velocity sedimentation at unit gravity of C57BL/sa/Fiii small spleen cells activated for 2 d 
with LPS •  =  erythrocytes;  •  =  small cells; O  =  IgM-secreting plaque-forming cells; •  =  large 
cells. 
Sedimentation.  Velocity sedimentation  (9)  was  used  to  separate  large  activated  cells 
from  small  nonactivated  cells,  employing  a  stabilizing  gradient  of  2-4%  bovine 
serum  albumin.  Fig.  1  shows  such  a  separation  of 48  h  activated,  initially  small 
C57BL/6a/r~l-spleen  cells.  As  expected  (8),  the  large  cell  fractions,  from  fraction  25 
downward,  as  activated  cells, secreted  sufficient  amounts  of IgM  to  form protein  A- 
SRC-hemolytic  plaques,  whereas  the  small,  nonactivated  cells,  in  fractions  26  up- 
wards,  did not.  Such separations  were done with the other activations  (Table I) with 
very similar  results  yielding  fractions  of activated,  Ig-secreting  large  cells separated 
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FIG.  2.  Restimulation  of mitogen-activated B-cell blasts with the homologous  mitogen. C57BL/6a 
spleen cells were activated for 2 d with LPS, the blast cells enriched by velocity  sedimentation and 
thereafter restimulated with LPS (©). Control, no mitogen added to blasts (0). A, number of cells 
per culture. B, number of IgM-PFC per culture. 
Large, activated cells from fractions 10-20 (see Fig.  1) were pooled and used in the 
following experiments. 
Continuation of Growth and Maturation of Activated Splenic B Cells. 
IN THE  PRESENCE  OF  THE  SAME  MITOGEN  USED  DURING  THE  ACTIVATION  PERIOD.  The 
pool  of  activated,  large  cell  fractions  of  either  C57BL/~/F~I,  CaH/Tif/BOM,  or 
CaH/HeJ/F~I  mice were  resuspended  in  culture  medium  at  1  ×  105 cells/ml  in  the 
absence of the same mitogen used during the first  activation period. 
In the absence of mitogen, cells ceased to grow after  1 d. They continued to secrete 
sufficient  amounts  of IgM to  keep  the  number  of IgM-PFC in  culture  practically 
constant over the next 4 d whereafter a  decline in the number of PFC was apparent 
(shown in Fig. 2 for C57BL/~ spleen cells). It indicates that activated B cells need the 
continued presence of mitogen to grow and to increase their number of IgM-PFC.  a It 
appeared  that  the  PFC  developed  in  the  first  activation  period  continued,  in  the 
improved tissue culture medium, to secrete IgM for several days without dividing any 
further in the absence of added mitogen. 
This finding suggests that B-cell blasts already activated for high rate Ig secretion 
do not easily revert to a nonsecreting, resting B cell.  In fact, the number of IgM-PFC 
(but not the number of cells  in culture) assayed at day 0 and  1 of restimulation were 
always higher in  the absence of mitogen than in  its  presence  (Fig.  2, 4).  This could 
indicate that the addition of mitogen to mitogen-activated blasts may favour growth 
and  consequently disfavour secretion.  This  finding could also be  interpreted  as  an 
effector cell blockade, mediated by the mitogen. 
C57BL/~/Fal  and  CaH/Tif/BOM large  cells  activated  by  either  LPS  or  LP,  and 
CaH/Hea/wal large cells,  activated by LP, continued to  grow in  the  presence of the 
homologuous mitogen for 4  d  with  doubling times of 218 h.  The number of IgM- 
secreting PFC also increased for the next 4 d. It is, however, evident from the data in 
Fig.  2 that  the number of secreting cells  was never equal to the number of growing 
3  Lernhardt, W., and F. Melchers. Manuscript in preparation. JAN  ANDERSSON  ET  AL.  557 
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Fro.  3.  Restimulation  of mitogen-activated  B-cell  blasts with  beterologous  mitogens.  C57BL/~ 
spleen cells were activated for 2 d with LPS, the blast cells enriched by velocity sedimentation and 
thereafter  restimulated  with LP  (O), NOC  (/X), or mFCS (0).  A,  number of cells per culture.  B, 
number of IgM-PFC  per culture. 
TABLE II 
Maturation after Restimulation of B-Cell Blasts* to IgG-Secreting PFC 
Mitogen  IgG PFC/3  X  105 cul- 
tured B-cell blasts 
First  activation period  Restimulated with  (Assays at day 5 of re- 
stimulation) 
LPS  LPS  4.5  X  104 
LPS  LP  3.2  X  104 
LP  LP  4.8  x  104 
LP  LPS  4.0  x  104 
* C57BL/e,a/~i~l  small  spleen  cells  stimulated  for  2  d  in  the  first  activation 
period. 
cells although the ratio of secreting to growing cells increased from 0.016 at day  1 to 
0.36 at day 4 of restimulation. 
IN THE  PRESENCE  OF A MITOGEN  DIFFERENT FROM  THAT USED  DURING  THE ACTIVATION 
PERIOD.  The pool of activated,  large cells, resuspended at  1  ×  10 5 cells/ml  in fresh 
medium,  was  also  cultured  in  the  presence  of a  mitogen  different  from  that  used 
during the first  activation period. In addition to LPS and LP, NOC and mFCS were 
used. 
Judged  by  the increase  in  the  number of cells  in  culture and by the number of 
IgM-PFC  developing in the cultures continuation of growth and maturation  in the 
presence of either of the heterologous mitogens was as efficient  as in the presence of 
the homologuous mitogen which was used in the activation period  (Fig. 3, Table II). 
The  kinetics  of continued  growth  in  the  presence  of a  heterologous  mitogen  also 
appeared  indistinguishable  from  those in the presence of the homologuous mitogen 
(compare Figs.  2 and 3). The LPS-nonreactive C3H/Hea/Vfil spleen cells, activated  for 
2  d  by LP, continued to grow and mature in the presence of NOC  and mFCS,  but 558  B-CELL BLASTS REACTIVE TO MORE THAN ONE MITOGEN 
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FIe. 4.  Restimulation ofLP-activated CaH/Hea-splenic  B-cell blasts with LP (©), NOC (A), mFCS 
(I~), LPS (A), or no mitogen (O). A, number of cells per culture. B, number of IgM-PFC per culture. 
not in the presence of LPS (Fig. 4). 
These results suggest the majority of the large B-cell blasts, activated by either LPS 
or  LP,  are  reactive  to  more  than  one  mitogen.  Because  CsH/HeJ/Fpl  B-cell  blasts, 
activated by LP, continue to grow and mature with NOC and mFCS, but not with 
LPS, it suggests that the stimulation to continued B-cell growth and IgM secretion is 
not  unspecific,  but  depends  on  the  expression  of reactivities  (receptors)  for  these 
different  mitogens  which,  at  least  in  the  case  of  LPS,  represents  a  genetically 
discernible property of B cells. It indicates that one activated B cell expresses different 
reactivities, and thus probably receptors specific for the different B-cell mitogens. 
Maturation  to IgG-Secreting  Cells.  Restimulation of mitogen-activated blast cells by 
either homologuous mitogen lead to activation of B-cell clones to IgG-secretion. For 
the  case  of LPS  and  LP,  it  was  evident  that  the  height  of the  IgG-PFC response 
measured at day 6, 7, and 8 of stimulation (shown in Table II for day 7 of stimulation, 
i.e.,  at  day  5  of  restimulation)  was  very  similar  for  both  mitogens  with  either 
homologuous or heterologous stimulation. These results indicate that similar numbers 
of IgG-secreting B-cell clones develop under these different conditions of growth and 
restimulation. 
Frequency Analyses of Mitogen-Reactive  B-Cells.  The results presented above indicate 
that a high number of initially small, resting B cells are stimulated by LPS or LP to 
growing B-cell blasts, and that a high proportion of these B-cell blasts are reactive to 
both  the  homologous  and  to  heterologous  mitogens.  To  determine  the  number  of 
reactive growing B cells more exactly, we have analyzed the frequencies of reactive B 
cells at limiting dilutions of reactive cells in cultures which allow the growth of every 
growth-inducible  mitogen-reactive B  cell as a  single clone of cells  (2).  Thus,  small, 
resting B cells, or LPS- or LP-activated B-cell blasts (separated by velocity sedimen- 
tation  as  shown  in  Fig.  1)  were  diluted  serially  3.3-fold  in  medium  containing  rat 
thymus cells as fillers and  a  given mitogen, either LPS or LP. These analyses were 
done with CsH/Tif/BOM, CaH/HeJ/Fiil,  and C57BL/ea/Fiil spleen cells. 
Table  III  summarizes  these  frequency  analyses.  They  confirm  the  conclusions 
reached from the experiments shown before and show that approximately one of three 
splenic  B  cells  of CS/Tte/BOM and  C57BL/6j/eal  mice  are  reactive  to  LPS  and  LP, JAN ANDERSSON ET AL. 
TABLE III 
Frequencies of LPS- and of LP-Reactive B-Cells in All Small, Resting Spleen Cells (in 
All Small Splenic B Cells) 
559 
Strain  LPS  LP  0 
C57BL/ea/Fill  1 in 7 (1 in 3.5)  1 in 6 (1 in 3)  <1 in 104 
C3H/Tif/BOM  1 in 6  (1 in 3)  1 in 7 (1 in 3.5)  <1 in  10  4 
CsH/nea/Fiil  <1  in 104  1 in 8  (1 in 4)  <1 in  104 
TABLE IV 
Frequencies of LPS- and of LP-Reactive B Cells in All Mitogen-Activated 
Blast Cells 
Mitogen 
used in first 
Strain  LPS  LP  0  activation 
period 
C57BL/~J/Fila  LPS  I in 1.35  1 in 1.5  1 in 104 
LP  1 in  1.4  1 in 1.35  1 in 104 
C3H/Tif/BOM  LPS  1 in  1.2  1 in 1.3  1 in 104 
LP  1 in  1.35  1 in  1.4  1 in  104 
CaH/rt~j/Fiit  LPS  (No blasts)  (No blasts)  -- 
LP  1 in  104  I in 1.5  1 in 104 
yielding  a  clone  of IgM-secreting cells  at  day  5,  and  approximately one  of three 
splenic B cells of C3H/nea/Fia mice are reactive to LP, whereas < 1 in 104 B cells of this 
mouse  strain  is  reactive  to  LPS.  These  frequencies  are  in  agreement  with  earlier 
determinations  (4). 
Mitogen-activated blasts,  as expected, show an even higher  frequency of reactive 
cells  when  regrown  with  the  homologous  mitogen  and  assayed 4  d  later  for IgM- 
secreting  B  cells  (Table  IV).  When  regrown  with  the  heterologous  mitogen,  B-cell 
blasts of C57BL/0J/F~ and C3H/Tif/BOM spleen cells show frequencies which are near 
or  identical  to  those  obtained  with  the  homologous mitogen.  This  suggests  that  a 
large part of all mitogen-activated B cells in their activated state carry more than one 
mitogen  reactivity.  C3H/neJ/ria  LP-reduced  blasts,  as  expected  from  their  genetic 
defect and from the experiments shown above, do not continue to grow in the presence 
of LPS. The frequency of LPS-reactive cells in this blast population is <1 in  104 blast 
cells. 
In summary, the experimental data presented  in  this paper suggests that  a  large 
part of all small, splenic B cells activated by one mitogen, develop into blasts which 
carry reactivities and, therefore, probably receptors, for more than one B-cell mitogen. 
Discussion 
Our  previous  frequency analyses of the  number of mitogen-reactive B  cells had 
yielded  1 of 3 splenic B cells to be reactive to LPS and  1 in 3.5  splenic B cells to be 
reactive to LP (4). The question which arose from this result was whether the same or 
different B cells were reactive for the different B-cell mitogens. We first attempted to 560  B-CELL BLASTS REACTIVE TO MORE THAN ONE MITOGEN 
approach this  problem  experimentally  by determining  the  frequency of reactive  B 
cells in the presence of more than one mitogen. This proved to be a difficult approach 
possibly due  to the  fact that  B-cell  mitogens show a  dose optimum with  high dose 
inhibition of stimulation. Consequently, addition of two mitogens, each at their dose 
optimum, may in fact lead to inhibition. 
The experimental approach which we have used in this report, i.e., the restimulation 
of mitogen-activated B-cell blasts was successful, because it proved possible to wash 
out  the  mitogen  used  in  the  first  activation  period,  a  result  which  could  not  be 
expected a  priori from the lipophilic nature of both LPS and LP. The washed blasts 
finish  the  cell  cycle which  they  have  begun  and  come  to  rest  after  the  following 
mitosis. 3 A  disadvantage  of the  restimulation  of activated  blast  cells  is  that  our 
conclusion  of one  B  cell  expressing  more  than  one  mitogen  reactivity  and  thus, 
probably one receptor, can only be stated  for activated B-cell blasts but not yet for 
resting,  small  B  cells.  Thus,  it  is  theoretically  still  possible  that  the  activation  of 
originally nonmitogen-reactive resting  B  cells  leads  to  the  functional  expression  of 
new mitogen reactivities  (receptors)  in the same cells after blast transformation. 
The genetic defect of C3H/Hej B-cells  in their responsiveness to LPS could not be 
overcome by a  first  activation period in the presence of LP: the blast cells  remained 
unreactive to LPS. This further documents the LPS-specificity of the defect which is 
most easily explained by a defect in the putative mitogen-receptor for LPS in a B-cell 
population  which  is  present  in  normal  numbers  and  in  which  all  other  reactions 
leading to growth and maturation (inducible i.e., by LP) are normal. It suggests that 
multiple mitogen reactivities  (receptors) must coexist on the same B cell. 
The  conclusions  from  our  present  experiments  must,  however,  be  considered  in 
quantitative  terms.  Thus,  it  is  obvious  from  all  the  data  that  twofold  differences 
would  have  escaped  our  analysis,  in  comparing  the  reactivities  to  two  distinct 
mitogens.  It  should  also  be  considered  that  the  large  cell  fraction  used  in  our 
experiments as blasts include a variable but minor proportion of contaminating small 
cells  which  could  account  for some of the  reactivity  to  any  mitogen  tested  in  the 
secondary cultures. 
It follows that, although we have no way of assaying for the reactivity of all blasts 
induced by any mitogen, it  is clear that  a  large fraction of all  B-cell  blasts  express 
several mitogen reactivities (receptors) including those for LPS, LP, NOC, and mFCS. 
The  principle  of one  B  cell  being  reactive  to  more  than  one  growth-inducing 
mitogenic stimulus certainly does not rule out B cells  reactive to only some or only 
one type of mitogenic stimulus. Proposals have been made for describing B-cell subsets 
as displaying arrays of selective responsiveness to various mitogens, due to a selective 
expression of a particular receptor in a certain fraction of B cells (17, 18). Experimental 
evidence supporting the  existence  of B-cell subsets  has  been  obtained  not  only for 
several  mitogens  but  also  for  T-cell  dependent  and  T-cell  independent  antigens 
(19-21). It has been found that B-cells  arise ontogenically displaying a  limited array 
of reactivities (16, 22-24). Thus, fetal liver cells which become LPS-reactive in vivo or 
in  vitro  at  the  time  or  the  equivalent  time  of birth  (24) show  a  10-fold  reduced 
reactivity to LP or to mFCS (16,  25).  Along the normal differentiative pathways, B 
cells may first  be reactive to only one mitogen and acquire more receptors to become 
multireactive  at  later  stages.  Thereafter,  they also  begin  to  lose  reactivities  again. JAN ANDERSSON ET AL.  561 
Thus, we have found that splenic B cells from 1-yr-old mice are no longer reactive to 
either LPS or LP (4), but are apparently still reactive to T-cell help. All these results 
argue for the existence of B-cell populations which do not react to all mitogens, and 
therefore,  argue  for  the  selective  expression  of mitogen  reactivities  (receptors)  in 
subsets of cells. Each lymphoid organ with B cells should, therefore, contain varying 
proportions of the different subsets. At present we have no idea which factors influence 
the development of the different  B-cell subsets,  although  age and strain  differences 
are candidates for such influences (4,  18). 
One B-cell subset, which, at present, escapes the types of analyses'which we have 
applied  to B cells using external mitogens such as LPS,  LP, NOC, or mFCS, is the 
subset which is reactive to T-cell help. We have failed so far to meet the conditions 
under which addition of T-cell help to B cells would allow polyclonal activation of all 
B  cells  potentially,  and  irrespective  of the  specificity  of their  Ig-variable region- 
binding  sites,  reactive to  T-cell help.  The exact  quantitative  analysis of the  B-cell 
repertoire for T-cell help must await such conditions where all potentially stimulatable 
cells can be triggered by T-cell help. One can, however, attempt to qualify a certain 
B-cell population as to whether it can react at all to T-cell help or not. In the presence 
of erythrocyte antigens,  B  cells  are capable to react  by growth  and  maturation  to 
antibody-secreting cells,  providing  that  T-cell  help  is  added,  either  in  the  form of 
activated T  cells (26-29)  or of culture supernates from activated T-cells (30-32).  We 
have probed our LPS- or LP-activated blast B-cells with sheep erythrocytes (SRC) as 
antigen  together with  activated T  cells or Con  A-supernates of spleen  cells  for the 
capacity of antigen-specific B-cell blasts to continue  growth and  maturation.  From 
the preliminary experiments,  which  we have accumulated  so far, it  appears that  a 
majority of the antigen-specific B-cell blasts among the mitogen-activated B-cell blasts 
can be restimulated by antigen plus T-cell help. 
This suggests, so far in a  circumstantial way, that a  majority of all splenic B-cells 
of  2-3  mo-old  mice  (C57/BL/6j  and  C3H/Tif), activated  to  their  blast  stage  by 
mitogen, are multireactive to several external mitogens and to T-cell help. 
In conclusion, we view the B-cell compartment as being composed ofsubpopulations 
differing in  their reactivities  to external  mitogens and  to T-cell help.  We postulate 
that  mature,  small  B  cells  express  at  least  one  mitogen  reactivity  as  a  necessary 
prerequisite  for responsiveness.  B-cell subsets may exist in which each cell expresses 
all mitogen reactivities (receptors) of the species. Other B-cell subsets, however, must 
also  exist  which  do  not  express  the  whole  array of reactivities  (33).  We conclude, 
therefore, that of any limited collection of mitogens tested, target B cells with multiple, 
as well as with apparent single, reactivities will be found. Finally, the finding of cells 
with  apparent  unireactivity does not  exclude  that  such  cells would  respond  to any 
number of other mitogens, not tested in a particular experiment. 
If B-cell  development  of mitogen-reactivities  is  independent  of VH-VL-idiotype 
expression, we may expect the repertoire of VH-VL-idiotypes to be the same in different 
subpopulations. Alternatively, if VH-VL-gene products influence the differentiation of 
mitogen reactivities (receptors) on B cells, then we may expect the selective expression 
of antibody repertoires associated with various B-cell reactivities, because the somatic 
generation of such repertoires must be dependent  upon the functional reactivities of 
the cells. 562  B-CELL BLASTS REACTIVE  TO MORE THAN ONE MITOGEN 
Summary 
One  of three  splenic  B  cells  of 2-  to  3-mo-old  C57BL/6j  or  Call/Tit  mice  are 
activated  either  by lipopolysaccharide  (LPS)  or by lipoprotein  (LP)  to grow and  to 
mature  to  IgM-secreting cells.  When  mitogen-activated  blast  cells,  after  a  2-d  acti- 
vation period, are separated from nonactivated, small ceils by velocity sedimentation, 
and  no mitogen  is  readded,  the  blasts  do not  continue  to grow but  do continue  to 
secrete IgM for several days. When the homologous mitogen is added for restimulation, 
the  blast  cells  continue  for several  days  to  divide  every  18  h  and  to develop  IgM- 
secreting, plaque-forming cells. Frequency analyses at limiting dilutions of reactive B- 
blasts  show  that  one  cell  in  ~1.2-1.5  blasts  continue  to  grow  and  mature  in  the 
presence  of the  homologous  mitogen,  either  LPS  or  LP.  When  the  B-cell  blasts 
obtained  in a  first  activation  period with either  LPS or LP are restimulated  with  a 
heterologous mitogen, LPS, LP, Nocardia mitogen or mitogens contained in fetal calf 
serum a high proportion of the blasts continue to grow and to mature to IgM-secreting 
cells.  Frequency analyses show for LPS- or LP-blasts, restimulated  in a  heterologous 
fashion with either LP or LPS, that one cell in  1.35-1.5 blasts continue to divide and 
to  mature  to  IgM-secreting  ceils.  C3H/Hea-splenic  B-cells,  which  are  LPS  nonre- 
sponders, can only be activated to blast cells by LP. These LP-activated blasts can be 
restimulated  by the homologous LP and by Nocardia mitogen and mitogens of fetal 
calf serum, but not by LPS. 
The results indicate that the majority of splenic B cells of 2- to 3-mo-old C57BL/6j 
or CaH/T~ mice are reactive to more than one B-cell mitogen. B cells, therefore, can 
possess  in  their  surface  membrane  multireactive  mitogen-receptor complexes which 
regulate growth and maturation. 
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